Axo Longevity has closed $5 million in a seed funding round amid growing demand for its preventive health testing services. The startup currently operates in the United Kingdom, Ireland, Spain, Germany, the Netherlands and Peru, and plans to expand into additional global markets.
The investment round was backed by MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment, alongside angel investors including Dr. Jorge Planas of Clinica Planas Barcelona and Daniel Kulle, former President of H&M and former CEO of Forever 21.
“Europe has exceptional clinical infrastructure, but for consumers it is fragmented, and they might only be able to access it when they are sick,” explains Sergio Tang, Co-founder and Chief Product and Growth Officer at Axo Longevity. “We are delivering a single membership experience that works seamlessly and equips people with a data-driven understanding of their health – and a clear action plan of exactly what to do next.”
Sergio Tang said: “This funding will allow us to grow our laboratory network, continue to develop our AI health copilot and wearable integrations, and expand our services into the Nordics, Italy and Portugal.”
According to our latest funding insights, digital health companies, including digital wellness startups, have raised more than $20 billion in VC funding so far the year. More recently, Function Health, a provider of membership-based personalized health and wellness tests, has raised $450 million in a new growth funding round from General Catalyst’s Customer Value Fund.
In another deal, Throne Science, a maker of an AI-powered smart toilet sensor that tracks gut health, hydration, and urinary function automatically with every flush, raised $10 million in a Series A round led by Will Ventures.